Seelos Therapeutics Inc (SEEL): RE: AF on Femprox comment about whether...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Seelos Therapeutics Inc (SEEL)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	17
Posts	2968
Boards Moderated	0
Alias Born	02/24/2012

Re: eicoman post# 8121

Friday, 07/05/2013 2:35:29 PM

Friday, July 05, 2013 2:35:29 PM

RE: AF on Femprox comment about whether the China trial will be good enough, he will probably use the guidance on new PH3 trials as a negative, saying something like another set back, when the company has clearly stated the China trial was not sufficient and they have positive guidance coming for new PH 3 trials, which will start in 2014 and only take 6 months to complete.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SEEL News

Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM

More SEEL News

InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow